Experience

Virtus Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Manager - Pricing and Contract Analytics

  • Dec 2022 - Present

• Senior Contracts and Pricing Analyst

  • May 2017 - Present



Sandoz

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Pricing Analyst II

  • Jan 2011 - May 2017

  Reviewed RFPs including GPO customer (Request for Proposals) / IFB (Invitations for Bid) for all classes of trade to ensured proposals meet all financial objectivesParticipated in pricing & cost proposal development and provide pricing for 1,500+ molecules, both blockbusters and niche products for all major therapeutic areas – including generic anti-infective, generic injectables, generic dermatologic, ophthalmic and biosimilarsRecommended methods, procedures and techniques for pricing proposals – including price increases, WAC and AWP changes, possible allocation holds in preparation for API material shortagesEnsured price proposals are prepared and loaded to customer contracts in accordance with T&C, applicable laws and regulations Provided RFP Cost Volume requirements – translating them into a fully compliant pricing & cost proposal including Product Specific Rebates (PSR) to reach customer financial value

• Fixed Asset Accountant

  • Jan 2009 - Jan 2011

  Audited monthly expenses, and prepared journal entries, accruals, transfers and bill out expenses to cost centersProvide regional and district manages with support on month and year end closes, resolving P&L discrepancies, liabilities, setting up new accounts, and FDA notifications of assets transfers/retirementsAnalysis, tracked and managed investment budgets and report on all Capital Appropriation Requests to project managers for reviewAssisted with quarter end and year end audits with regards to fixed assets, capital expenditures and depreciation including the preparation of internal and external audit work papers in accordance with GAAP and company policyPrepared and posted amortization or depreciation of capital expenditure costs

• Senior Credit Analyst

  • Apr 2002 - Jan 2009

  Extended credit to approved customers in a manner which achieves overall company objectives while maximization of net profit on salesAnalyzed financial strength & stability with (D&B Reports/F&D Reports/Vendor References/Credit Group Information) also recommended terms & credit limits to CFOReviewed full aging once per month (including past due invoices, deduction analysis & cash forecast analysis)Processed all lockbox & EFT transmissions from previous day bank deposits that were reported from SAP, including investigating debits variances and credit variances that are left open on the accountReviewed all IPA, pricing and shortage claims taken on EFTs checks